不同手术方式对Ⅰ期子宫内膜样腺癌患者生存及复发的影响
本文选题:Ⅰ期子宫内膜样腺癌 切入点:盆腔淋巴结清扫术 出处:《河北医科大学》2017年硕士论文 论文类型:学位论文
【摘要】:目的:近年来子宫内膜癌的发病率呈逐渐上升趋势,且高收入国家的发病率高于低收入国家。由于子宫内膜癌患者早期常有异常阴道出血的症状,能够及时就诊,多数患者(75%)确诊时属于Ⅰ期,因此子宫内膜癌的预后普遍较好。目前子宫内膜癌的治疗仍是以手术治疗为主,以放化疗和激素治疗为辅的综合治疗。2015年FIGO指南指出I期子宫内膜癌的基本术式是筋膜外全子宫加双侧附件切除术,然而2016年NCCN指南推荐若无手术禁忌和技术限制,最好还是行全面分期手术(盆腹腔冲洗液留取脱落细胞+全子宫双附件切除术+盆腔及腹主动脉旁淋巴结清扫术)。目前对于Ⅰ期子宫内膜样腺癌患者行盆腔及腹主动脉旁淋巴结切除的治疗价值仍存在很大争议。本研究拟通过比较不同手术方式对I期子宫内膜样腺癌患者生存及复发的影响,以期为Ⅰ期子宫内膜样腺癌的处理提供参考依据。方法:回顾性分析2005年1月-2014年12月期间于河北医科大学第二医院行手术治疗的Ⅰ期子宫内膜样腺癌患者199例。根据手术方式不同分为两组:A组行全子宫+双侧附件切除术,共88例,B组行全子宫+双侧附件切除术+盆腔淋巴结清扫术,共111例。对两组的术后并发症发生率、复发率及生存率进行比较。结果:A、B两组之间术后并发症的发生率相比具有统计学意义(P=0.020.05),两组之间复发率相比无统计学差异(P=0.400.05),1年、3年、5年生存率相比亦无统计学差异(P分别为0.259、0.427、0.713,,均0.05)。结论:对于I期子宫内膜样腺癌患者行盆腔淋巴结清扫术有助于明确手术病理分期,但并不能提高患者的生存率和降低复发率,反而会增加术后并发症的发生率。
[Abstract]:Objective: in recent years, the incidence of endometrial cancer is increasing, and the incidence rate is higher than the high income countries in low income countries. Due to the early endometrial cancer patients often have abnormal vaginal bleeding symptoms, to timely treatment, most patients (75%) belong to the stage at diagnosis, so the prognosis of endometrial cancer is generally better at present the treatment of endometrial carcinoma is mainly treated by operation, the comprehensive treatment of.2015 chemotherapy and hormone therapy supplemented by the FIGO guidelines pointed out that basic surgery for stage I endometrial cancer is extrafascial hysterectomy and bilateral adnexectomy, while the 2016 NCCN guidelines recommend if no contraindications and technical limitations, or for the best comprehensive staging surgery (pelvic peritoneal lavage fluid collected exfoliated cells + hysterectomy + pelvic and paraaortic lymphadenectomy). For patients with stage I endometrial adenocarcinoma Therapeutic value of pelvic and paraaortic lymph node dissection is still controversial. This study by comparing the different surgical methods influence on stage I endometrioid adenocarcinoma patients survival and recurrence, to provide reference for the treatment of stage I endometrial adenocarcinoma. Methods: a retrospective analysis of January 2005 -2014 in December, during the stage I endometrial adenocarcinoma patients in the second hospital of Hebei Medical University underwent surgery in 199 cases. According to the operation were divided into two groups: group A underwent hysterectomy and bilateral adnexectomy, a total of 88 cases, group B underwent hysterectomy plus bilateral accessory resection and pelvic lymph node dissection, a total of 111 The incidence of two cases. Postoperative complications, recurrence rate and survival rate were compared. Results: A, B rate compared with statistical significance between the two groups of postoperative complications between the two groups (P=0.020.05), the recurrence rate compared with no statistical differences ( P=0.400.05), 1 years, 3 years, 5 years survival rate also compared no significant difference (P = 0.259,0.427,0.713, 0.05). Conclusion: for patients with stage I endometrial adenocarcinoma pelvic lymph node dissection can help clear the surgical pathological staging, but did not improve survival and reduce the recurrence rate, but will increase the incidence of postoperative complications.
【学位授予单位】:河北医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.33
【参考文献】
相关期刊论文 前10条
1 徐珍;彭芝兰;曾俐琴;罗喜平;;358例子宫内膜癌手术方式及影响预后的危险因素分析[J];实用妇产科杂志;2015年04期
2 刘怡;杨佳欣;刘石萍;单莹;李晓燕;;早期子宫内膜癌盆腔淋巴结切除的意义探讨[J];中国妇产科临床杂志;2015年02期
3 曹丽娜;尹香花;;子宫内膜癌术后辅助治疗选择的分析[J];医学综述;2014年08期
4 赵灵琴;陈曦;陈鲁;;早期子宫内膜癌盆腔及腹主动脉旁淋巴结清扫术的作用[J];临床肿瘤学杂志;2012年07期
5 王志启;张燕;王建六;沈丹华;赵昕;姚远洋;白云;魏丽惠;;子宫内膜癌淋巴结转移的特征及对预后的影响[J];中华妇产科杂志;2011年06期
6 徐文生;居晓庆;;早期子宫内膜癌腹膜后淋巴结清扫及术后放疗疗效的系统评价[J];广西医科大学学报;2011年03期
7 单波儿;孙织;王华英;任玉兰;;系统的淋巴结清扫术在子宫内膜癌治疗决策中的价值及可行性分析[J];中国癌症杂志;2009年12期
8 李斌;吴令英;李晓光;鲁海珍;白萍;李淑敏;章文华;高菊珍;;前哨淋巴结识别技术在子宫内膜癌的研究[J];中国肿瘤临床;2008年11期
9 颜笑健;李光仪;陈露诗;王刚;尚慧玲;林铁成;韩玉斌;关锦图;;宫颈癌与子宫内膜癌前哨淋巴结检测的初步探讨[J];实用妇产科杂志;2007年12期
10 吴鸣,沈铿,郎景和,黄荣丽,黄惠芳,潘凌亚,邓元琪;子宫内膜癌206例临床分析[J];中华妇产科杂志;2002年10期
,本文编号:1580386
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1580386.html